Pfizer Total Non-Operating Income/Expense 2010-2024 | PFE
Pfizer total non-operating income/expense for the twelve months ending June 30, 2024 was $-0.752B, a 206.67% decline year-over-year.
- Pfizer annual total non-operating income/expense for 2023 was $0.835B, a 484.79% decline from 2022.
- Pfizer annual total non-operating income/expense for 2022 was $-0.217B, a 104.45% decline from 2021.
- Pfizer annual total non-operating income/expense for 2021 was $4.878B, a 502.14% decline from 2020.